article promise microheteroplasmy theory disease text pdf anyone microheteroplasmy theory disease correspondence rafal genciabiotech.com hypertension author form mutation microheteroplasmy candidate component presence organism mutation % abundance majority burden germline development life microheteroplasmy pathomechanism involvement disease disease s disease cancer microheteroplasmy disease inheritance explanation course Introduction biology biology mtDNA ontogeny disease evidence hypertension theory hypothesis theory microheteroplasmy stem theory opportunity Conclusion Introduction decline failure complexity contiguity organism time complexity contiguity face entropic energy appropriation dissipation crucial maintenance complexity integrity information progerias failure maintenance development stem generation stress repopulation age relevance integrity time contrast perspective pathophysiology accompany risk atherosclerosis Involvement complex analysis number protein folding processing degradation accumulation toxic gene majority observation absence gene consideration cause role pathomechanism form causative case none ontogeny accumulation lipofuscin protein substrate factor disease change time DNA half-life accumulation information loss replication feat turnover synthesis accumulation change contexts glycation turnover candidate substrate disease cell time lead dysfunction information loss time loss form loss accumulation importance point discussion mechanism stress stress inflammation aggregation mechanism accumulation concept carcinogenesis proliferation theory theory result damage oxygen replication impairment phosphorylation failure production maintenance cell death damage loss tissue function energy loss decline energy production provider contiguity theory energetic/metabolic decline age theory fraction population range onset form damage microheteroplasmy accumulation confer proclivity disease determine extent rate age rate accumulation mtDNA timing onset modulation component clock practice sequencing mtDNA sequencing extension refinement theory exposition literature disease case microheteroplasmy factor explanation failure field level biology biology mtDNA -proteobacteria genome phosphorylation apoptosis cell death genome mtDNA time discovery DNA kb dsDNA molecule electron transport chain tRNA rRNA translation protein cell mtDNA mtDNA genome copy presence mutation % homoplasmy heteroplasmy mixture locus MtDNA line detection degree inheritance trait number mutation mutation mutation present percentage % % heteroplasmy manifestation infancy childhood adulthood addition specific ontogeny germ line state metaphase division turnover mtDNA replication replacement half-life Accumulation repair accumulation number survival selection mtDNA majority line apoptosis maturation Accumulation mtDNA threshold mechanism mtDNA apoptosis element sensing mechanism accumulation production oxygen susceptibility phosphorylation leakage agent maturation germline metabolism time formation fetus initiation cycle woman metabolism phosphorylation embryos mtDNA output apoptosis production ova embryos mtDNA cleansing mechanism mtDNA mutation survival ovum fetus % mutation line concentration range % and/or polymerase family polymerase domain exonuclease capability processivity subunit family polymerization exonuclease domain advantage fact exonuclease domain mtDNA accumulation mtDNA ontogeny excellent exonuclease capability evidence criticism focus mtDNA polymerization repair bottleneck mtDNA accumulation study exonuclease capacity study dNTP vivo representation dGTP overrepresentation mutagenesis increase base pair error dNTP error rate mtDNA mutation accumulation explanation mechanism mtDNA mutation accumulation absence damage presence mtDNA DNA template DNA method detection % product mixture loci chromatogram peak component noise sensitivity % sensitivity class focus article technique sensitivity % confirmatory sequencing mutation state field structure light body mitochondrial deafness syndrome disorder percentage form load microheteroplasmy mtDNA mutation present % mtDNA fragment sequence cloning signal percentage mutation ratio vs. procedure sequencing microheteroplasmy microheteroplasmy accumulation exception substantia nigra brainstem level microheteroplasmy birth contrast microheteroplasmy form burden % level % % level patient burden level mutation mitochondrial distribution genome control region mutation frequency coding genome percentage amino mutation mutation tRNA rRNA gene control region % mutation level mutation level genome adult point majority age mitochondria form burden accumulation rat rhesus monkey muscle muscle % presence negativity % muscle rhesus monkey % lead sensitization contrast estimate % load magnitude introduction finding mtDNA sequencing majority correlation number correlation phenotype presence genome gene presence algorithm method control study region contrast gene parkin date combination dysfunction section result evidence involvement mtDNA disease study correlation presence microheteroplasmy microheteroplasmy genome clock inheritance change disease disease evidence evidence involvement matrilineal inheritance correlation mtDNA mtDNA replication disease phenotype vitro vivo replication biochemistry mtDNA disease detection stress development phenotype localization/interaction disease replication induction mtDNA damage disease susceptibility mtDNA evidence hypertension cancer Neurodegeneration disease deficiency electron transport chain al deficit disease substantia nigra dysfunction rotenone form disease administration rotenone consistent condition degeneration asymmetry rate degeneration cause exposure environment progression frequency situation part electron transport chain activity brain inhibitor decline stress deposition tau protein discovery model therapy importance mitochondria pathogenesis polymerase polymerase polymerase administration accumulation mtDNA dysfunction pathology parallel parkinsonism research model hybrid mtDNA mitochondria patient hybrid background gene complement way genome physiology cell DNA inheritance abnormality mitochondria deficiency cell protein membrane become mtDNA carrier information dysfunction addition deficiency exhibit number patient calcium homeostasis production aggregation form dysfunction brain output deposition literature localization/interaction gene section protection risk haplogroups impact dysfunction event pathomechanism aggregation discovery protein role way focus accumulation protein homeostasis cell face stress material histopathology disease material relevance majority hypertension evidence involvement type hypertension case % testing % inheritance number mutation % population mutation variant evidence role dysfunction etiology insulin resistance activity offspring insulin resistance predictor dysfunction development Work mouse model insulin resistance insulin receptor insulin resistance gene expression dysfunction cause effect insulin resistance dysfunction mechanism alloxane streptozotocin cause animal stress susceptibility case hypertension stress factor model causation aging system component inheritance hypertension % mtDNA hypertension inheritance hypertension hypercholesterolemia hypomagnesemia mtDNA mutation production model hypertension dysfunction event pathogenesis hypertension interpretation mtDNA dysfunction event epiphenomenon event pathogenesis Cancer cancer glycolysis exclusion metabolism energy production mtDNA majority tumor date evolution neoplasm focus research mtDNA exploration role biochemistry tumor formation side equation reliance tumor metabolism mtDNA phosphorylation cell dependent glycolysis perspective series single-cell form slime mold switch mode competition glucose cooperation hand metabolism energy utilization cell multicellularity fact form lineage endosymbiosis gain oxygen utilization step formation success multicellularity ability low-cooperativity state potential devoid mtDNA propensity gene expression reminiscent state dysfunction mitochondrial muscle activity cell cycle increase tumorigenesis mice increase potential expression gene picture process cell adaptation role coherent explanation mtDNA involvement cancer role apoptosis role production function production mtDNA attrition instability maintenance chain production accumulation rise act production electron transport master master gene expression state adaptation production generation plasma membrane membrane motility metastasis burden lack metabolism shift gene expression state ability mitochondria cell cell death program causal relationship accumulation mtDNA loss mouse model DNA version polymerase accumulation mtDNA phenotype osteopenia kyphosis alopecia loss cardiomegaly al life span stress regulator retina brain background role pathway help point rheostat cell cell s energy evidence matrilineal inheritance transmission pathology mtDNA evidence abnormality form stress replication theory hypothesis obstacle acceptance theory lack set estimate total % evidence mtDNA clock mtDNA percentage hypertension minority type mtDNA mutation gene mutation deletion increase frequency minority % minority muscle correlation paradigms restriction accumulation deletion level reversal phenotype mtDNA change clock mtDNA damage theory inheritance effect effect Hypertension effect % study effect percentage factor inheritance accumulation mtDNA variation accumulation decline activity aging activity inheritance lack decline activity muscle selection loss notion mtDNA damage ability phosphorylation theory theory discovery microheteroplasmy section microheteroplasmy majority % adult mutation genome fraction level par existence amplification impact dysfunction e.g individual substrate clock neonate increase age quantity integrator damage time rate accumulation brain substantia nigra level bp age group cortex level age group stress source substantia nigra level generation synthesis dopamine presence phenotype control accuracy value determinant development % mutation codon childhood disorder level % gene dosage effect phenylketonuria level mutation childhood phenotype level dysfunction objection theory lack evidence presence load dearth mtDNA methodology detection reliance microscope existence degree inheritance contributing attention community heredity explanation section germline mtDNA stringent mutation exhaustion germline selection number mtDNA ovum assertion complex dysfunction presence development zygote germline transmission observation inheritance et al load mtDNA cell drift mutation present mtDNA ovum time level organism objection theory disease degree inheritance dysfunction outline mtDNA mutation ontogeny fig objection section model cardiomyopathy hypermutable polymerase heart association cell loss dysfunction activity loss al theory accumulation misinformation lack information research accumulation description production upregulation production apoptosis fig hypothesis summary microheteroplasmy presence mtDNA present level % mtDNA tissue burden % factor pathology hypertension accumulation production form gain-of-function production mechanism phosphorylation turn impairment function include accumulation lipofuscin amyloid inclusion insulin resistance microheteroplasmy combination germline formation zygote lifespan individual contribution mother sufficient matrilineal inheritance disease location quantity microheteroplasmy part variation example development microheteroplasmy drift mutation load onset cell mutation burden threshold incompatibility function al mutation tip iceberg microheteroplasmy base production link microheteroplasmy aging category upregulation enzyme reserve turnover protein damage production ability damage microheteroplasmy function machinery damage mitochondria damage concept involvement support study extension mice catalase enzyme mitochondria expression catalase mitochondria nucleus slowing damage presence cell complementation generation form gain function complementation cell mechanism microheteroplasmy cell metabolism regulation energy metabolism glycolysis shift section cancer hypertension s disease correlation deposition generation review fact inhibitor oxidase phenomenon explanation cognitive deficit overproduction mitochondria loss function mitochondria access energy function brain microheteroplasmy dysfunction production downstream signal redox status ratio redox plasma membrane activity production mechanism peptide metabolism hypothesis fact toxicity fact energy glycolysis molecule status function generation molecule hypertension regulator nitrosylation fact nitrosylation modification cytosol milieu cell response order tissue biogenesis Upregulation biogenesis role generation turnover amount effect usage tioglitazone piogliazone mitobiogenesis reserve term reason increase mitochondria damage warning disease context toxicity microheteroplasmy inheritance disease development mother stage oocyte development number oocyte compatible maturation oocyte apoptosis loci oocyte oocyte set mother accumulation number number factor number mutation average distribution number oocyte distribution genome example embryogenesis mtDNA example complex inheritance concordance cortex level concordance observation above mechanism half ooplasm correlation distribution mtDNA conception stem microheteroplasmy accumulation stem cause exhaustion tissue renewal capacity age equilibrium cell loss renewal stem e.g cortex time apoptosis stem fraction tissue abundance stem longevity progeny microheteroplasmy accumulation microheteroplasmy stem stem capacity mtDNA mutation burden microheteroplasmy time exhaustion stem mesencephalon zone mechanism loss function Analysis microheteroplasmy stem quantification potential prediction course tissue hypothesis body inheritance pathophysiology question paragraph article dysfunction age clock mechanism phenomenon body microheteroplasmy bill number example causation answer question aggregation -amyloid clock process protein aggregation protein modification time-keeping accumulation change hypothesis insulin resistance hypothesis microheteroplasmy hypothesis accumulation insulin resistance causal level description insulin receptor phenotype hypothesis mechanisms mtDNA path framework microheteroplasmy clock framework knowledge pathology form parkin impact mitochondria stress degradation accumulation component microheteroplasmy cell ability example apoptosis response task part processing activity onset loss age onset inflammation autoimmunity aggregation insulin resistance dysfunction research inflammation generation contribute acceleration relationship degree inheritance condition age onset age tend matrilineal inheritance age onset degree matrilineal inheritance combination germline contribution age phenotype phenotype age mutation level age relationship mutation concert gene pace phenotype resistance dysfunction exposure development pathology Accumulation change genome hypothesis shortening metabolism involvement cancer senescence loss potential culture body evidence importance change versus microheteroplasmy microheteroplasmy classification patient influence mechanism microheteroplasmy production activity apoptosis failure stem cell renewal attrition gene mutation detail genome venture microheteroplasmy example accumulation glycation protein turnover tissue level research impact importance microheteroplasmy % burden role question accumulation microheteroplasmy result microheteroplasmy circle mutation generation data load process opinion premise hypothesis crux hypothesis clock movement link mtDNA point hypermutable polymerase mouse model cardiomyopathy absence production model accumulation aging enzyme birth heart deletion week cardiomyopathy mutation bp cardiomyopathy administration cyclosporin activity microheteroplasmy accumulation period magnitude dysfunction cyclosporin mouse model production state research tissue specificity mutation accumulation threshold level heteroplasmy phenotype phenotypic threshold microheteroplasmy substantia plateau accumulation cell rise appearance question absence damage repair accumulation mtDNA mechanisms impact health longevity soma theory cost mtDNA repair sufficient procreation fertility age environment adaptiveness infection predation homicide fertility reduction fertility fitness analysis mtDNA repair issue issue question advantage mtDNA expansion research advantage mtDNA process basis theory sequencing mtDNA seem absence advantage cell hypothesis issue cancer development absence frequency cancer dysfunction cancer mortality neoplasia theory hypothesis number section microheteroplasmy germline conception contribution mother differentiation patient patient microheteroplasmy overlap sequencing extent dysfunction transmissible mtDNA analogy microheteroplasmy mtDNA burden mitochondrial e.g sequencing sequencing analysis diagnosis prognosis level inheritance hypertension evidence dysfunction microheteroplasmy specific addition mutation evidence involvement location microheteroplasmy phenotypic survival ovum survival pathology death homoplasmy Analysis hypertension microheteroplasmy accumulation rate microheteroplasmy production restriction production slowing accumulation accumulation stem cause exhaustion tissue renewal capacity age analysis microheteroplasmy stem quantification potential prediction course tissue Menopause germline fraction ova mtDNA ovum apoptosis ova microheteroplasmy phenotypic syndrome accumulation amyloid age level microheteroplasmy interference trisomy apoptosis gene dosage chromosome Replacement mtDNA opportunity case removal amyloid intervention microheteroplasmy role stimulation mitobiogenesis acceleration mtDNA attrition insulin resistance Replacement Microheteroplasmy magnitude burden candidate substrate hypothesis bridge mtDNA mutation aggregation framework hypothesis inheritance delay onset hypothesis information energy loss component work Evolution Rise integrity :923-928 Regulation stress self-renewal stem Nature :997-1002 al s disease gene chromosome s disease type gene Nature :775-778 al gene bearing s disease Nature :754-760 al s disease susceptibility gene :512-521 et al Mutation gene disease Science :2045-2047 al gene cause juvenile parkinsonism Nature :605-608 van al gene parkinsonism Science :256-259 al s disease Science :1158-1160 :25-36 s disease :153-169 disease :44-70 :683-697 atherosclerosis pesticide exposure disease :1301-1306 der al phosphorylation tau process plasticity :6972-6981 al enzyme brain proteolysis beta vasculotropic activity amyloid angiopathy :56004-560013 body formation mutant huntingtin risk death Nature :805-810 prototypic neoplasm :57-60 overview oncogenesis :13-18 clock mitochondria :145-147 pathophysiology cell death Science :626-629 frequency complex disease :1273-1281 algorithm analysis disease Intelligence press burden mtDNA point disease brain :133-145 Cantuti-Castelvetri al DNA press al DNA cortex substantia nigra disease :71-81 s disease :667-669 Ephrussi synthesis respiratory yeast Nature :1207-1208 evolution mitochondria :205-212 analysis DNA polymerase chain reaction polymerase chain reaction :180-186 inheritance mitochondria class detection involvement :1515-1526 :267-277 oogenesis preimplantation embryogenesis metabolism regulation competence Reproduction :269-280 turnover variety adult :2425-2429 accumulation point mtDNA control region replication Science :774-779 al mtDNA control replication :4022-4027 et al mtDNA point :5521-5526 expansion process :49-53 attrition :101-108 death Nature :500-501 Tatemoto porcine cell death stress maturation role :805-810 function electron transport chain glucose catabolism maturation vitro Reproduction :675-681 dysfunction mouse preimplantation embryo arrest vitro :1936-1942 :429-439 al Cosegregation pedigree :1894-1899 onset degree heteroplasmy A transition :784-786 al Premature mice polymerase Nature :417-423 Construction mice acceleration mutagenesis :151-161 DNA precursor tissue contribution replication fidelity :4990-4995 screening genome high-performance liquid chromatography :61-74 al presentation deafness :303-313 al polymorphisms risk disease dementia :29-35 medicine cardiomyopathy phosphorylation :371-395 al mutation disorder :1041-1050 mechanism :1-7 muscle rhesus monkeys :91-101 muscle rhesus :123-138 al heteroplasmy :43-49 mtDNA deletion :289-293 theory :11-17 s mtDNA control-region transcription replication :10726-10731 electron transport chain s disease :719-723 Inhibition oxidation brain metabolite neurotoxin :2503-2508 exposure :409-414 deficiency s disease :1302-1303 s model poison sodium azide :31-40 polymerase gamma account toxicity :45-57 dysfunction reverse transcriptase inhibitor therapy :189-197 brain accumulation al s disease model disease :918-925 transmission defect disease :177-186 calcium homeostasis mitochondria disease :1221-1233 al oxygen enzyme animal disease :77-86 disease inclusion :800-812 al disease cell death :148-155 substantia pathology transgenic mice treatment :158-172 al parkin stress :71-84 neurodegeneration disease Science :819-822 al presenilin form gamma-secretase mitochondria :51654-51660 al expression amyloid precursor protein mice up-regulation metabolism change s disease :1225-1240 transmembrane arrest s amyloid precursor protein function :41-54 al Inhibition c beta :672-679 dysfunction s disease toxicity :1417-1426 glucose metabolism mice plaque pathology :77-94 neurotoxicity glycolysis inhibition impairment rat hippocampus vivo nerve s disease :163-174 al haplogroup risk disease :748-752 der al risk disease :804-811 et al s disease :194-198 :325-343 variant insulin resistance life :54-58 variant evidence case-control study :1581-1583 al prevalence variant association fasting glucose body mass index :681-684 al variant infarction evidence case-control study :317-324 growth insulin resistance al dysfunction role insulin resistance Science :1140-1142 activity offspring :664-671 al muscle oxygen uptake function offspring :2126-2132 turnover tissue lipolysis type insulin resistance phenomenon :1572-1578 al versus gene expression vivo analysis mice :16525-16530 disease immunodeficiency virus :314-324 mechanism alloxan action rat pancreas :537-546 stress :655-673 disease :529-536 al cluster mutation tRNA Science :1190-1194 hydrogen peroxide production risk hypertension :291-303 response angiotensin :152-166 DNA disease aging neurodegeneration heart failure cancer :429-441 al signature cancer marker tumor progression :6674-6681 dysfunction :270-280 competition evolution Science :504-507 scenario transition multicellularity :1095-1098 connection origin cell :1599-1618 hypothesis geochemistry :59-83 al evolution cell death multicellularity :235-249 stress phenotypic tumor progression cell invasion :1910-1920 E purifying selection variation mtDNA Science :223-226 cycle cardiac muscle myopathy :695-699 al mtDNA tumorigenicity prostate cancer :719-724 al contribution genome promotion cancer prevention apoptosis :1655-1663 response cancer :6641-6646 dysfunction attrition instability :40-46 stress instability mouse :277-285 impairment repair nucleus Mutagenesis :497-503 al respiratory chain content tumor aggressiveness cell carcinoma Carcinogenesis :759-768 role tumor progression Oncologist :10-17 gene mutation cancer :4991-5004 tumor suppressor :2816-2819 al role tumor suppressor protein stimulation phosphorylation biogenesis Carcinogenesis :531-539 al oxygen transcription factor differentiation mechanism effect :40462-40469 factor tumor progression pathway :157-213 plasma membrane oxidoreductase prerequisite viability rho :30097-30100 et al oxidoreductase activity relation function stress :251-258 al oxidase growth apoptosis prostate cancer :353-369 al control neurodegeneration :1153-1158 :171-174 electron transport hub :21-27 al frequency mtDNA mutation remodeling replication origin :1116-1121 al deletion heart relationship :1-5 al analysis :111-114 Measurement deletion level rat liver brain restriction diet :269-273 risk dementia s disease evidence inheritance :254-256 inheritance disease :265-268 al ratio disease :129-133 al relationship level electron transport chain muscle :536-539 evidence theory study muscle mitochondria :877-886 age respiratory chain activity muscle :73-82 Trounce muscle respiratory chain function factor :637-639 mtDNA :89-94 disease :809-814 complex gene hot-spot :128-132 cancer disease mechanism :1323-1325 al pathway cause :147-157 revealing order chaos :122-132 heart disease mortality :169-174 damage turnover mitochondria :770-778 deficiency import repair :10670-10675 axis theory accumulation mitochondria result autophagocytosis :1996-2002 culture stress accumulation turnover :70-77 damage :957-968 al Extension Science print al tRNA suppressor mutation mitochondria :350-353 amyloid cascade hypothesis senile amyloid-beta disease :1-4 importance morphogenesis plasticity :873-887 protection death role redox state :260-269 tolerance mice Neuroscience :285-289 activity cell mitochondria :1-5 Induction apoptosis beta :117-125 inhibition nitrosylation site cysteine oxidase lung et al Effect oxide respiratory activity :388-395 inhibition complex :394-400 respiratory complex oxide :44-49 al biogenesis :16507-16512 formation localization :117-122 al overproduction megamitochondria :136-147 dysfunction proliferator :477-482 al induction coactivator receptor biogenesis cardiomyopathy manner :525-533 evidence heritability disease Neurology :305-311 cytoskeletal consequence head injury :171-178 al :211-220 et al protein immunoreactivity aging disease Neuroscience :1-13 al crypt stem :1351-1360 al efficacy versus progenitor model disease :175-183 zone stem adult brain :703-716 onset beta-amyloid beagle :269-273 al activity-regulating efficacy amyloid precursor protein heparin-binding domain :1882-1896 al beta alcohol dehydrogenase component response stress :27100-27109 cell death s disease :604-609 cascade hypothesis s disease :8-20 al damage s disease genotype :297-303 biology cancer :32-38 tumor suppressor breast cancer diagnostic Oncologist :361-377 al regulation damage brain Nature :883-891 mechanisms cell apoptosis :1281-1289 al Time immutability :452-462 discussion et al muscle point impairment function :484-493 disease mouse stress :4820-4825 damage mutation decline respiratory function :155-170 stress mediator disease :35-45 disease cyclosporin :1210-1215 stress s disease viability apoptosis pro-death signaling exposure control :312-322 Evolution Nature :301-304 selection accumulation cerevisiae :3690-3694 refinement theory :161-166 al accumulation syndrome brain :88-102 gene replacement therapy :387-393 Figure mutation accumulation ontogeny mtDNA germline life purple Post-conception stem reserve life generation role selection depletion stem survival outline mechanism microheteroplasmy event mtDNA mutation generation damage mtDNA cell ensue suppression magnitude overproduction energy production cell accumulation dysfunction mail.gmail.com < pop.cris.net > pdf anyone file Rafal rafal.smigrodzki gmail.com text pdf anyone reading digestion work review mitochondrial/ROS theory review mind damage result mechanism clock role mainstream mechanism attention aspect review field system research example gene funding gene gene genome mind argument microheteroplasmy variation mitochodria turnover rate mitochondria variation competition cell process germline mtDNA mechanism proof-reading mt-DNA evidence mtDNA exist form genome level model result mtDNA replication germline sequence reason organism cell quicker age age age aspect theory paper assay type oligo custom microarray genome kb rho-DNA germline mtDNA mtDNA contamination s evidence theory reason age soma hypothesis hypothesis reason age maintenance organism integrity breeding age hypothesis study literature mice cause assertion course role host damage example work rise phenotype phenotype phenotype i.e theory clock kind way warranty term ontotype influence aging phenotype pathotype pathotype i.e damage lipofucin field phenomenon microheteroplamy role development pathotype assertion clock rise ontotype case ontotype function function result gene expression means program cell adult organism example wound repair supressor majority s senescence skin gain function elastin collagen cell chop surveilance epithelium ontotype cancer cancer part pathotype intent article lot field research analog synthesis theory data piece puzzle solution puzzle work email stuart sign life universe spam spam protection http //mail.yahoo.com